179 related articles for article (PubMed ID: 36374036)
1. Maternal heterozygosity of Slc6a19 causes metabolic perturbation and congenital NAD deficiency disorder in mice.
Cuny H; Bozon K; Kirk RB; Sheng DZ; Bröer S; Dunwoodie SL
Dis Model Mech; 2023 May; 16(5):. PubMed ID: 36374036
[TBL] [Abstract][Full Text] [Related]
2. NAD deficiency due to environmental factors or gene-environment interactions causes congenital malformations and miscarriage in mice.
Cuny H; Rapadas M; Gereis J; Martin EMMA; Kirk RB; Shi H; Dunwoodie SL
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3738-3747. PubMed ID: 32015132
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide Adenine Dinucleotide Deficiency and Its Impact on Mammalian Development.
Dunwoodie SL; Bozon K; Szot JO; Cuny H
Antioxid Redox Signal; 2023 Dec; 39(16-18):1108-1132. PubMed ID: 37300479
[No Abstract] [Full Text] [Related]
4. A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder.
Szot JO; Cuny H; Martin EM; Sheng DZ; Iyer K; Portelli S; Nguyen V; Gereis JM; Alankarage D; Chitayat D; Chong K; Wentzensen IM; Vincent-Delormé C; Lermine A; Burkitt-Wright E; Ji W; Jeffries L; Pais LS; Tan TY; Pitt J; Wise CA; Wright H; Andrews ID; Pruniski B; Grebe TA; Corsten-Janssen N; Bouman K; Poulton C; Prakash S; Keren B; Brown NJ; Hunter MF; Heath O; Lakhani SA; McDermott JH; Ascher DB; Chapman G; Bozon K; Dunwoodie SL
J Clin Invest; 2024 Feb; 134(4):. PubMed ID: 38357931
[TBL] [Abstract][Full Text] [Related]
5. NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
Shi H; Enriquez A; Rapadas M; Martin EMMA; Wang R; Moreau J; Lim CK; Szot JO; Ip E; Hughes JN; Sugimoto K; Humphreys DT; McInerney-Leo AM; Leo PJ; Maghzal GJ; Halliday J; Smith J; Colley A; Mark PR; Collins F; Sillence DO; Winlaw DS; Ho JWK; Guillemin GJ; Brown MA; Kikuchi K; Thomas PQ; Stocker R; Giannoulatou E; Chapman G; Duncan EL; Sparrow DB; Dunwoodie SL
N Engl J Med; 2017 Aug; 377(6):544-552. PubMed ID: 28792876
[TBL] [Abstract][Full Text] [Related]
6. Stage-Specific L-Proline Uptake by Amino Acid Transporter Slc6a19/B
Treleaven T; Zada M; Nagarajah R; Bailey CG; Rasko JEJ; Morris MB; Day ML
Cells; 2022 Dec; 12(1):. PubMed ID: 36611813
[TBL] [Abstract][Full Text] [Related]
7. First person - Hartmut Cuny.
Dis Model Mech; 2023 May; 16(5):. PubMed ID: 36374035
[TBL] [Abstract][Full Text] [Related]
8. Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency.
Belanger AJ; Gefteas E; Przybylska M; Geller S; Anarat-Cappillino G; Kloss A; Yew NS
J Inherit Metab Dis; 2023 Jan; 46(1):55-65. PubMed ID: 36220785
[TBL] [Abstract][Full Text] [Related]
9. SLC6A19 is a novel putative gene, induced by dioxins via AhR in human hepatoma HepG2 cells.
Tian W; Fu H; Xu T; Xu SL; Guo Z; Tian J; Tao W; Xie HQ; Zhao B
Environ Pollut; 2018 Jun; 237():508-514. PubMed ID: 29522993
[TBL] [Abstract][Full Text] [Related]
10. NAD+ deficiency in human congenital malformations and miscarriage: A new model of pleiotropy.
Mark PR
Am J Med Genet A; 2022 Sep; 188(9):2834-2849. PubMed ID: 35484986
[TBL] [Abstract][Full Text] [Related]
11. The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19.
Böhmer C; Sopjani M; Klaus F; Lindner R; Laufer J; Jeyaraj S; Lang F; Palmada M
Cell Physiol Biochem; 2010; 25(6):723-32. PubMed ID: 20511718
[TBL] [Abstract][Full Text] [Related]
12. Bi-allelic Mutations in NADSYN1 Cause Multiple Organ Defects and Expand the Genotypic Spectrum of Congenital NAD Deficiency Disorders.
Szot JO; Campagnolo C; Cao Y; Iyer KR; Cuny H; Drysdale T; Flores-Daboub JA; Bi W; Westerfield L; Liu P; Leung TN; Choy KW; Chapman G; Xiao R; Siu VM; Dunwoodie SL
Am J Hum Genet; 2020 Jan; 106(1):129-136. PubMed ID: 31883644
[TBL] [Abstract][Full Text] [Related]
13. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19.
Seow HF; Bröer S; Bröer A; Bailey CG; Potter SJ; Cavanaugh JA; Rasko JE
Nat Genet; 2004 Sep; 36(9):1003-7. PubMed ID: 15286788
[TBL] [Abstract][Full Text] [Related]
14. The role of the neutral amino acid transporter B0AT1 (SLC6A19) in Hartnup disorder and protein nutrition.
Bröer S
IUBMB Life; 2009 Jun; 61(6):591-9. PubMed ID: 19472175
[TBL] [Abstract][Full Text] [Related]
15. Metabolome-wide association study of the relationship between chlorpyrifos exposure and first trimester serum metabolite levels in pregnant Thai farmworkers.
Liang D; Batross J; Fiedler N; Prapamontol T; Suttiwan P; Panuwet P; Naksen W; Baumert BO; Yakimavets V; Tan Y; D'Souza P; Mangklabruks A; Sittiwang S; Kaewthit K; Kohsuwan K; Promkam N; Pingwong S; Ryan PB; Barr DB;
Environ Res; 2022 Dec; 215(Pt 2):114319. PubMed ID: 36108722
[TBL] [Abstract][Full Text] [Related]
16. New aspects for the brain in Hartnup disease based on mining of high-resolution cellular mRNA expression data for SLC6A19.
Kravetz Z; Schmidt-Kastner R
IBRO Neurosci Rep; 2023 Jun; 14():393-397. PubMed ID: 37101820
[TBL] [Abstract][Full Text] [Related]
17. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.
Kleta R; Romeo E; Ristic Z; Ohura T; Stuart C; Arcos-Burgos M; Dave MH; Wagner CA; Camargo SR; Inoue S; Matsuura N; Helip-Wooley A; Bockenhauer D; Warth R; Bernardini I; Visser G; Eggermann T; Lee P; Chairoungdua A; Jutabha P; Babu E; Nilwarangkoon S; Anzai N; Kanai Y; Verrey F; Gahl WA; Koizumi A
Nat Genet; 2004 Sep; 36(9):999-1002. PubMed ID: 15286787
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of amino acid transporter SLC6A19 activity and surface protein abundance by PKB/Akt and PIKfyve.
Bogatikov E; Munoz C; Pakladok T; Alesutan I; Shojaiefard M; Seebohm G; Föller M; Palmada M; Böhmer C; Bröer S; Lang F
Cell Physiol Biochem; 2012; 30(6):1538-46. PubMed ID: 23234856
[TBL] [Abstract][Full Text] [Related]
19. The female mouse is resistant to mild vitamin B
van der Stelt I; Shi W; Bekkenkamp-Grovenstein M; Zapata-Pérez R; Houtkooper RH; de Boer VCJ; Hegeman MA; Keijer J
Eur J Nutr; 2022 Feb; 61(1):329-340. PubMed ID: 34338868
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting neutral amino acid transport for the treatment of phenylketonuria.
Belanger AM; Przybylska M; Gefteas E; Furgerson M; Geller S; Kloss A; Cheng SH; Zhu Y; Yew NS
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
